Global Equine Healthcare Market 2015-2019

世界における馬の健康管理市場:診断製品、治療製品、遺伝子型分析

◆タイトル:Global Equine Healthcare Market 2015-2019
◆商品コード:IRTNTR5065
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2015年1月21日
◆ページ数:90
◆資料形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:農林水産
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Five UserUSD3,000 ⇒換算¥339,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、世界における馬の健康管理市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、世界における馬の健康管理市場規模及び予測、製品別分析、需要先別分析、市場シェア、地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About Equine Healthcare
Equine health refers to veterinary services intended to treat horses to enhance their quality of life, increase their lifespan, and develop better quality animal food. Equine diagnostic products, equine therapeutic products, and equine supplement products are the three major product types discussed in this report. Equine diagnostic products help to detect bacteria, antibodies, and viruses; equine therapeutic products include vaccination that helps treat any disease condition; and equine supplement products help in maintaining specific requirement of supplements.

TechNavio’s analysts forecast the Global Equine Healthcare market to decline at a CAGR of 1.24 percent over the period 2014-2019.

[Covered in this Report]
This report covers the present scenario and the growth prospects of the Global Equine Healthcare market for the period 2015-2019. To calculate the market size, the report considers revenue generated through the sales of various equine healthcare products. In terms of product, the Global Equine Healthcare market can be divided into three segments: Equine Diagnostic Products, Equine Therapeutic Products, and Equine Genotype Analysis.
TechNavio’s report, the Global Equine Healthcare Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Equine Healthcare market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

[Key Regions]
• Americas
• APAC
• EMEA

[Key Vendors]
• Affymetrix
• Bayer Health Care
• Boehringer Ingelheim
• Elanco Animal Health
• Merck Animal Health
• Purina Animal
• Zoetis

[Other Prominent Vendors]
• Boerhringer Ingelheim Vetmedica
• Ceva Holdings
• Merial
• Novartis Animal Health
• Signostics
• Vetoquinol

[Market Driver]
• Increase in Demand
• For a full, detailed list, view our report

[Market Challenge]
• Decrease in Global Equine Population
• For a full, detailed list, view our report

[Market Trend]
• Increase in Awareness
• For a full, detailed list, view our report

[Key Questions Answered in this Report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction

06.Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis

07.Market Segmentation by Products
07.1 Global Equine Vaccines Market
07.1.1 Market Size and Forecast

08.Geographical Segmentation

09.Buying Criteria

10.Market Growth Drivers

11.Drivers and their Impact

12.Market Challenges

13.Impact of Drivers and Challenges

14.Market Trends

15.Trends and their Impact

16.Vendor Landscape
16.1 Competitive Scenario
16.1.1 Key News
16.1.2 Mergers and Acquisitions

17.Market Share Analysis 2014
17.1 Affymetrix
17.2 Bayer Health Care
17.2.1 Segmentation by End-user
17.3 Boehringer Ingelheim
17.4 Elanco
17.4.1 Segmentation by End-user
17.4.2 Segmentation by Geography
17.5 Merck Animal Health
17.5.1 Segmentation by End-user
17.5.2 Segmentation by Geography
17.6 Purina Animal
17.7 Zoetis
17.7.1 Segmentation by Species Type
17.7.2 Segmentation by Product Type
17.7.3 Segmentation by Geography
17.7.4 Segmentation by Country
17.7.5 Segmentation by End-user
17.8 Other Prominent Vendors

18.Key Vendor Analysis
18.1 Affymetrix
18.1.1 Key Facts
18.1.2 Business Overview
18.1.3 Business Segmentation
18.1.4 Business Segmentation by Revenue 2013
18.1.5 Business Segmentation by Revenue 2012 and 2013
18.1.6 Sales by Geography
18.1.7 Business Strategy
18.1.8 Key Information
18.1.9 SWOT Analysis
18.2 Bayer HealthCare
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Business Segmentation by Revenue 2013
18.2.4 Business Segmentation by Revenue 2012 and 2013
18.2.5 Geographical Segmentation by Revenue 2013
18.2.6 Business Strategy
18.2.7 Recent Developments
18.2.8 SWOT Analysis
18.3 Boehringer Ingelheim
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Business Segmentation by Revenue 2013
18.3.4 Business Segmentation by Revenue 2012 and 2013
18.3.5 Geographical Segmentation by Revenue 2013
18.3.6 Business Strategy
18.3.7 Recent Developments
18.3.8 SWOT Analysis
18.4 Elanco Animal Health
18.4.1 Key Facts
18.4.2 Business Overview
18.4.3 Business Strategy
18.4.4 Recent Developments
18.4.5 SWOT Analysis
18.5 Merck Animal Health
18.5.1 Key Facts
18.5.2 Business Overview
18.5.3 Business Strategy
18.5.4 Recent Developments
18.5.5 SWOT Analysis
18.6 Purina
18.6.1 Key Facts
18.6.2 Business Overview
18.6.3 Key Products
18.6.4 Business Strategy
18.6.5 Recent Developments
18.6.6 SWOT Analysis
18.7 Zoetis
18.7.1 Key Facts
18.7.2 Business Overview
18.7.3 Business Segmentation by Revenue 2013
18.7.4 Business Segmentation by Revenue 2012 and 2013
18.7.5 Geographical Segmentation by Revenue 2013
18.7.6 Business Strategy
18.7.7 Recent Developments
18.7.8 SWOT Analysis

19.Other Reports in this Series

[List of Exhibits]

Exhibit 1: Market Research Methodology
Exhibit 2: Global Equine Healthcare Market 2014-2019 (US$ billion)
Exhibit 3: Global Equine Healthcare Market: Segmentation by Product
Exhibit 4: Global Equine Healthcare Market: Segmentation 2014
Exhibit 5: Global Equine Vaccines Market 2014-2019 (US$ billion)
Exhibit 6: Global Equine Healthcare Market by Geographical Segmentation 2014
Exhibit 7: Affymetrix Year on Year Sales Comparison 2010-2013 (US$ million)
Exhibit 8: Bayer’s Revenue by Segment 2013
Exhibit 9: Bayer Animal Health: Segmentation by End-user
Exhibit 10: Eli Lilly: Revenue by Segment 2013
Exhibit 11: Elanco: Segmentation by End-user
Exhibit 12: Elanco: Revenue by Geography 2013
Exhibit 13: Merck: Revenue by Segment 2013
Exhibit 14: Merck Animal Health: Segmentation by End-user
Exhibit 15: Merck Animal Health: Segmentation by End-user
Exhibit 16: Merck Animal Health: Segmentation by Geography 2013
Exhibit 17: Land O Lakes Year on Year Sales Comparison 2010-2013 (US$ million)
Exhibit 18: Zoetis: Segmentation by Species Type
Exhibit 19: Zoetis: Revenue of Species Type Segmentation 2013
Exhibit 20: Zoetis: Segmentation by Product Type
Exhibit 21: Zoetis: Revenue of Product Type Segmentation 2013
Exhibit 22: Zoetis: Revenue of Geographical Segmentation 2013
Exhibit 23: Zoetis: Revenue Segmentation by Geography
Exhibit 24: Zoetis: Revenue of Country-wise Segmentation 2013
Exhibit 25: Zoetis: Segmentation by End-user
Exhibit 26: Zoetis: Revenue of End-user Segment 2013
Exhibit 27: Zoetis: Companion Animals Segmentation by Product Type
Exhibit 28: Zoetis: Companion Animals Segmentation by Species Type
Exhibit 29: Zoetis: Revenue of Companion Animals Segment by Species Type 2013
Exhibit 30: Zoetis: Revenue of Companion Animals Segment by Geography 2013
Exhibit 31: Affymetrix Inc.: Business Segmentation 2013
Exhibit 32: Affymetrix Inc.: Business Segmentation by Revenue 2013
Exhibit 33: Affymetrix Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 34: Affymetrix Inc.: Sales by Geography 2013
Exhibit 35: Bayer HealthCare: Business Segmentation by Revenue 2013
Exhibit 36: Bayer HealthCare: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 37: Bayer HealthCare: Geographical Segmentation by Revenue 2013
Exhibit 38: Boehringer Ingelheim: Business Segmentation by Revenue 2013
Exhibit 39: Boehringer Ingelheim: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 40: Boehringer Ingelheim: Geographical Segmentation by Revenue 2013
Exhibit 41: Purina: Key Products
Exhibit 42: Zoetis: Business Segmentation by Revenue 2013
Exhibit 43: Zoetis: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 44: Zoetis: Geographical Segmentation by Revenue 2013



【掲載企業】

Affymetrix , Bayer Health Care , Boehringer Ingelheim, Elanco Animal Health , Merck Animal Health, Purina Animal , Zoetis , Boerhringer Ingelheim Vetmedica, Ceva Holdings, Merial, Novartis Animal Health, Signostics, Vetoquinol

【資料のキーワード】

馬、健康管理、医療、診断製品、治療製品、遺伝子型分析、ワクチン

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[世界における馬の健康管理市場:診断製品、治療製品、遺伝子型分析] (Global Equine Healthcare Market 2015-2019 / IRTNTR5065)販売に関する免責事項
[世界における馬の健康管理市場:診断製品、治療製品、遺伝子型分析] (Global Equine Healthcare Market 2015-2019 / IRTNTR5065)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆